Twitxy Saved

RMD Open

Verified account This account is verified. Learn more

@bmj_rmdopen

RMD Open is an open access journal publishing high quality peer-reviewed original research covering the full spectrum of musculoskeletal disorders.
rmdopen.bmj.com Joined May 2024
123 Following 945 Followers 799 Posts

Latest posts 5

RMD Open Verified account @bmj_rmdopen
👶 Do frequent infections in the first 18 months of life raise the later risk of juvenile idiopathic arthritis? Two Scandinavian birth cohorts weigh in
👥 126,572 children from MoBa (Norway) and DNBC (Denmark), 428 with JIA; infection frequency reported prospectively by parents, in quartiles
🎯 Highest vs lowest infection quartile: aOR 1.38 (95% CI 1.03 to 1.84); after adjusting for antibiotics, aOR 1.24 (0.92 to 1.66)
🧬 JIA polygenic risk score (n=40,002) was not linked to infection frequency (aOR 1.00); overall gene-infection interaction not significant (p=0.58)
⚠️ A modest association, not explained by shared genetics: antibiotics, treatment-requiring infections, or both may lie on the pathway
🔗 doi.org/10.1136/rmdope…
RMD Open Verified account @bmj_rmdopen
👁️ Sjögren's disease is more than dry eyes: higher odds of six major ocular comorbidities, posterior segment included
📊 Cross-sectional study, Taiwan's Longitudinal Health Insurance Database 2010: 34,802 patients with SjD vs 138,146 propensity score-matched comparators
🎯 Glaucoma 17.13% vs 8.94% (aOR 2.20); uveitis 7.41% vs 3.92% (aOR 1.96)
🔍 Higher odds also for non-neovascular AMD (aOR 2.21), neovascular AMD (1.76), retinal vein occlusion (1.68) and diabetic retinopathy (1.15)
⚠️ Claims data cannot show which came first, but the authors support systematic ophthalmic assessment in SjD
🔗 doi.org/10.1136/rmdope…
rmdopen.bmj.com Increased prevalence of ocular comorbidities among patients with Sjögren’s disease Background Sjögren’s disease (SjD) is a systemic autoimmune disease primarily characterised by ocular and oral dryness. However, growing evidence suggests that it may also involve posterior segment...
RMD Open Verified account @bmj_rmdopen
🌍 What does axial spondyloarthritis look like across the Arab world? The PROSPA study by the ArLAR Research Group
👥 1112 adults with axSpA, 33 rheumatology centres, 15 countries (mean age 42.6 years, 63.8% male, median disease duration 10 years)
🦴 Radiographic axSpA predominated (r/nr ratio 3.7); peripheral arthritis 45.7%, coxitis 31.7%, uveitis 16.7%, psoriasis 17.4%; HLA-B27 positive in 51.5% of 615 tested
💊 bDMARDs used in 70.1%; 36.4% smoked and 5.2% had a history of tuberculosis
⚠️ North Africa had the worst PROs and lowest bDMARD use, but after adjustment region did not independently explain ASAS-HI: disease activity and function did
🔗 doi.org/10.1136/rmdope…
RMD Open Verified account @bmj_rmdopen
🫁 Do serum biomarkers mirror what quantitative CT sees in systemic sclerosis-associated ILD?
👥 Cross-sectional study: 82 consecutive patients with SSc, same-day serum sampling and HRCT; 59 (72%) had ILD
🎯 KL-6 was independently associated with ILD presence and had the strongest links with total ILD extent, ground-glass opacities and fibrotic abnormalities
🔍 CCL-18 tracked total extent and GGO; SP-D marked ILD presence but not burden; IL-33, IL-11 and MMP-12 showed no association
⚠️ IL-25 was higher in GGO-predominant patterns: a preliminary signal from a single cross-sectional cohort, to be validated
🔗 doi.org/10.1136/rmdope…
rmdopen.bmj.com Circulating biomarkers reflect distinct quantitative CT-defined features of systemic sclerosis-as... Background Interstitial lung disease (ILD) is a major determinant of morbidity and mortality in systemic sclerosis (SSc). Automated quantitative CT (qCT) enables reproducible assessment of ILD extent...
RMD Open Verified account @bmj_rmdopen
🎯 Do the treat-to-target goals in lupus protect against hard outcomes? A systematic review and meta-analysis of DORIS remission and LLDAS
📚 26 studies in the qualitative synthesis, 8 in the meta-analysis (search to 1 August 2025)
📉 Damage accrual: LLDAS HR 0.66 (95% CI 0.56–0.78), DORIS HR 0.60 (0.50–0.72)
🔥 Flares: LLDAS HR 0.53 (0.41–0.67), DORIS HR 0.45 (0.23–0.89); for LLDAS mainly severe flares (HR 0.32)
⚠️ Observational studies, substantial heterogeneity for flares (I² 56.6% and 77.3%) and limited mortality data; even short attainment helped, sustained helped more
🔗 doi.org/10.1136/rmdope…